312 Pill - purple yellow capsule/oblong
Pill with imprint 312 is Purple / Yellow, Capsule/Oblong and has been identified as Aspirin, Butalbital, Caffeine and Codeine Phosphate aspirin 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg. It is supplied by Mayne Pharma Inc.
Aspirin/butalbital/caffeine/codeine is used in the treatment of Headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine aspirin 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for 312

Aspirin, Butalbital, Caffeine and Codeine Phosphate
- Imprint
- 312
- Strength
- aspirin 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg
- Color
- Purple / Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Mayne Pharma Inc.
- National Drug Code (NDC)
- 68308-0312 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
corn starch,
silicon dioxide,
stearic acid,
D&C Yellow No. 10,
FD&C Yellow No. 6,
FD&C Blue No. 1,
D&C Red No. 33,
D&C Red No. 28,
titanium dioxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "312"
More about aspirin / butalbital / caffeine / codeine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: narcotic analgesic combinations
- En español
Patient resources
- Aspirin, butalbital, caffeine, and codeine drug information
- Butalbital, aspirin, caffeine, and codeine (Advanced Reading)
Other brands
Fiorinal with Codeine, Ascomp with Codeine
Professional resources
Other brands
Fiorinal with Codeine, Ascomp with Codeine
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.